Pomanda estimates the enterprise value of INFECTIOUS RECORDS LIMITED at £189.6k based on a Turnover of £300k and 0.63x industry multiple (adjusted for size and gross margin).
infectious records limitedEstimated Valuation
£2.5m
Pomanda estimates the enterprise value of INFECTIOUS RECORDS LIMITED at £2.5m based on an EBITDA of £300k and a 8.24x industry multiple (adjusted for size and gross margin).
infectious records limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of INFECTIOUS RECORDS LIMITED at £0 based on Net Assets of £-629k and 0.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Infectious Records LimitedOverview
Infectious Records Limited is a live company located in london, EC4N 6AF with a Companies House number of 02813148. It operates in the artistic creation sector, SIC Code 90030. Founded in April 1993, it's largest shareholder is
a & e records ltd
with a 100% stake. Infectious Records Limited is a mature,
micro sized company, Pomanda has estimated its turnover at
£300k with
unknown
growth in recent years.
Pomanda's financial health check has awarded Infectious Records Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 1 areas for improvement. Company Health Check FAQs
Health Rating2.5out of 5
2 Strong
2 Regular
1 Weak
Size
annual sales of £300k, make it in line with the average company (£348.9k)
£300k - Infectious Records Limited
£348.9k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- - Infectious Records Limited
- - Industry AVG
Production
with a gross margin of 100%, this company has a lower cost of product (53.4%)
100% - Infectious Records Limited
53.4% - Industry AVG
Profitability
an operating margin of 100% make it more profitable than the average company (2.1%)
100% - Infectious Records Limited
2.1% - Industry AVG
Employees
with 4 employees, this is below the industry average (6)
4 - Infectious Records Limited
6 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Infectious Records Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £75k, this is equally as efficient (£75.1k)
£75k - Infectious Records Limited
£75.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Infectious Records Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Infectious Records Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Infectious Records Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Infectious Records Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Infectious Records Limited
- - Industry AVG
INFECTIOUS RECORDS LIMITED financials
EXPORT
Infectious Records Limited's latest turnover from September 2024 is £300 thousand and the company has net assets of -£629 thousand. According to their latest financial statements, we estimate that Infectious Records Limited has 4 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Sep 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Turnover
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
3,260,000
3,391,000
5,980,000
159,000
172,000
28,000
Other Income Or Grants
Cost Of Sales
2,669,000
2,935,000
2,931,000
21,000
90,000
83,000
Gross Profit
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
591,000
456,000
3,049,000
138,000
82,000
-55,000
Admin Expenses
-12,000
-176,898
170,536
89,599
184,694
-362,927
-352,407
-181,190
Operating Profit
300,000
312,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
476,898
420,464
366,401
2,864,306
500,927
434,407
126,190
Interest Payable
Interest Receivable
Pre-Tax Profit
300,000
300,000
300,000
300,000
300,000
300,000
300,000
668,000
300,000
300,000
109,000
36,000
1,695,000
114,000
59,000
-51,000
Tax
-75,000
-66,000
-57,000
-57,000
-57,000
-57,000
-57,000
-130,000
-60,000
-60,000
-58,000
-33,000
212,000
Profit After Tax
225,000
234,000
243,000
243,000
243,000
243,000
243,000
538,000
240,000
240,000
51,000
3,000
1,907,000
114,000
59,000
-51,000
Dividends Paid
Retained Profit
225,000
234,000
243,000
243,000
243,000
243,000
243,000
538,000
240,000
240,000
51,000
3,000
1,907,000
114,000
59,000
-51,000
Employee Costs
2,268,921
78,954
77,110
Number Of Employees
4
4
5
5
5
4
4
4
4
4
41
41
81
3
3
EBITDA*
300,000
312,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
476,898
420,464
366,401
2,864,306
500,927
434,407
126,190
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Tangible Assets
11,000
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
11,000
Stock & work in progress
Trade Debtors
18,000
Group Debtors
2,049,000
2,262,000
2,273,000
626,000
Misc Debtors
1,000
1,000
1,000
1,000
61,000
121,000
180,000
213,000
22,000
Cash
misc current assets
total current assets
1,000
1,000
1,000
1,000
61,000
2,188,000
2,442,000
2,486,000
648,000
total assets
1,000
1,000
1,000
1,000
61,000
2,188,000
2,442,000
2,486,000
659,000
Bank overdraft
Bank loan
Trade Creditors
Group/Directors Accounts
629,000
854,000
1,088,000
1,331,000
1,574,000
1,818,000
2,061,000
2,304,000
2,842,000
3,142,000
11,000
234,000
other short term finances
hp & lease commitments
other current liabilities
66,000
305,000
204,000
427,000
3,000
3,000
total current liabilities
629,000
854,000
1,088,000
1,331,000
1,574,000
1,818,000
2,061,000
2,304,000
2,842,000
3,142,000
66,000
305,000
215,000
661,000
3,000
3,000
loans
5,443,000
5,508,000
5,646,000
5,280,000
5,393,000
5,452,000
hp & lease commitments
Accruals and Deferred Income
other liabilities
1,000
provisions
total long term liabilities
5,443,000
5,509,000
5,646,000
5,280,000
5,393,000
5,452,000
total liabilities
629,000
854,000
1,088,000
1,331,000
1,574,000
1,818,000
2,061,000
2,304,000
2,842,000
3,142,000
5,509,000
5,814,000
5,861,000
5,941,000
5,396,000
5,455,000
net assets
-629,000
-854,000
-1,088,000
-1,331,000
-1,574,000
-1,817,000
-2,060,000
-2,303,000
-2,841,000
-3,081,000
-3,321,000
-3,372,000
-3,375,000
-5,282,000
-5,396,000
-5,455,000
total shareholders funds
-629,000
-854,000
-1,088,000
-1,331,000
-1,574,000
-1,817,000
-2,060,000
-2,303,000
-2,841,000
-3,081,000
-3,321,000
-3,372,000
-3,375,000
-5,282,000
-5,396,000
-5,455,000
Sep 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Sep 2013
Sep 2012
Sep 2011
Sep 2010
Sep 2009
Operating Activities
Operating Profit
300,000
312,000
300,000
300,000
300,000
300,000
300,000
300,000
300,000
476,898
420,464
366,401
2,864,306
500,927
434,407
126,190
Depreciation
Amortisation
Tax
-75,000
-66,000
-57,000
-57,000
-57,000
-57,000
-57,000
-130,000
-60,000
-60,000
-58,000
-33,000
212,000
Stock
Debtors
-1,000
-60,000
-2,127,000
-254,000
-44,000
1,838,000
648,000
Creditors
Accruals and Deferred Income
-66,000
-239,000
101,000
-223,000
424,000
3,000
Deferred Taxes & Provisions
Cash flow from operations
225,000
246,000
243,000
243,000
244,000
243,000
243,000
170,000
300,000
2,477,898
377,464
478,401
1,015,306
276,927
434,407
129,190
Investing Activities
capital expenditure
11,000
-11,000
Change in Investments
cash flow from investments
11,000
-11,000
Financing Activities
Bank loans
Group/Directors Accounts
-225,000
-234,000
-243,000
-243,000
-244,000
-243,000
-243,000
-538,000
-300,000
3,142,000
-11,000
-223,000
234,000
Other Short Term Loans
Long term loans
-5,443,000
-65,000
-138,000
366,000
-113,000
-59,000
5,452,000
Hire Purchase and Lease Commitments
other long term liabilities
-1,000
1,000
share issue
-5,404,000
interest
cash flow from financing
-225,000
-234,000
-243,000
-243,000
-244,000
-243,000
-243,000
-538,000
-300,000
-2,301,000
-66,000
-148,000
143,000
121,000
-59,000
48,000
cash and cash equivalents
cash
overdraft
change in cash
infectious records limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for infectious records limited. Get real-time insights into infectious records limited's credit score, group structure and payment trends.
Perform a competitor analysis for infectious records limited by selecting its closest rivals, whether from the ARTS, ENTERTAINMENT AND RECREATION sector, other micro companies, companies in EC4N area or any other competitors across 12 key performance metrics.
infectious records limited Ownership
INFECTIOUS RECORDS LIMITED group structure
Infectious Records Limited has no subsidiary companies.
The sole shareholder of Infectious Records Limited is A & E Records Ltd.
a & e records ltd
100%
infectious records limited directors
Infectious Records Limited currently has 4 directors.
The longest serving directors include
Mr Stuart Bergen (May 2020) and
Mr Antony Harlow (Jan 2021).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to infectious records limited.
infectious records limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INFECTIOUS RECORDS LIMITED. This can take several minutes, an email will notify you when this has completed.
infectious records limitedCompanies House Filings - See Documents
